Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia

American Journal of Hematology

Volumn 88, Issue 4, 2013, Pages 277-282

  Visco, Carlo ^a   Moretta, Francesca ^b   Falisi, Erika ^a   Facco, Monica ^c   Maura, Francesco ^d   Novella, Elisabetta ^a   Nichele, Ilaria ^a   Finotto, Silvia ^a   Giaretta, Ilaria ^a   Ave, Elisa ^c   Perbellini, Omar ^b   Guercini, Nicola ^a   Scupoli, Maria Teresa ^b   Trentin, Livio ^c   Trimarco, Valentina ^c   Neri, Antonino ^d   Semenzato, Gianpietro ^c   Rodeghiero, Francesco ^a   Pizzolo, Giovanni ^b   Ambrosetti, Achille ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

AGED; ANTIGENS, CD38; FEMALE; GENE EXPRESSION; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84875596933     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23396     Document Type: Article

References (41)

1. Catovsky D. Chronic lymphoproliferative disorders. Curr Opin Oncol 1995;7:3-11.
2. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804-815.
3. Montserrat E. Chronic lymphoproliferative disorders. Curr Opin Oncol 1997;9:34-41.
4. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-1916.
5. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
6. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
7. Langerak AW, Davi F, Ghia P, et al. Immunoglobulin sequence analysis and prognostication in CLL: Guidelines from the ERIC review board for reliable interpretation of problematic cases. Leukemia 2011;25:979-984.
8. Rassenti LZ, Kipps TJ. Lack of allelic exclusion in B cell chronic lymphocytic leukemia. J Exp Med 1997;185:1435-1445.
9. Sanchez ML, Almeida J, Gonzalez D, et al. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood 2003;102:2994-3002.
10. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446-5456.
11. Rassenti LZ, Jain S, Keating MJ, et al. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 2008;112:1923-1930.
12. Haferlach C, Dicker F, Schnittger S, et al. Comprehensive genetic characterization of CLL: A study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007;21:2442-2451.
13. Evans PA, Pott Ch, Groenen PJ, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2007;21:207-214.
14. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
15. Ghia P, Stamatopoulos K, Belessi C, et al. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 2007;21:1-3.
16. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008;36(Web Server issue):W503-W508.
17. Bomben R, Dal Bo M, Capello D, et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study. Br J Haematol 2009;144:492-506.
18. Visco C, Maura F, Tuana G, et al. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors. Clin Cancer Res 2012;18:1870-1878.
19. Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: Implications for the role of antigen selection in leukemogenesis. Blood 2008;111:1524-1533.
20. Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007;109:259-270.
21. Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002;99:1023-1029.
22. Ibrahim S, Keating M, Do KA, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001;98:181-186.
23. Jelinek DF, Tschumper RC, Geyer SM, et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 2001;115:854-861.
24. Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893-901.
25. Schroers R, Griesinger F, Trumper L, et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005;19:750-758.
26. Morilla A, Gonzalez de Castro D, Del Giudice I, et al. Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL. Leuk Lymphoma 2008;49:2108-2115.
27. Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
28. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.
29. Shanafelt TD, Drake MT, Maurer MJ, et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 2011;117:1492-1498.
30. Rossi D, Sozzi E, Puma A, et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009;146:64-75.
31. Danese MD, Griffiths RI, Gleeson M, et al. An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia. Blood 2011;117:3505-3513.
32. Rassenti LZ, Kipps TJ. Expression of Ig-beta (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion. Blood 2000;95:2725-2727.
33. Balomenos D, Balderas RS, Mulvany KP, et al. Incomplete T cell receptor V beta allelic exclusion and dual V beta-expressing cells. J Immunol 1995;155:3308-3312.
34. Davodeau F, Peyrat MA, Romagne F, et al. Dual T cell receptor beta chain expression on human T lymphocytes. J Exp Med 1995;181:1391-1398.
35. Rossi D, Spina V, Deambrogi C, et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 2011;117:3391-3401.
36. Sanchez ML, Almeida J, Lopez A, et al. Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: Biclonality versus intraclonal evolution of a single tumor cell clone. Haematologica 2006;91:331-339.
37. Frezzato M, Giaretta I, Madeo D, et al. Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several years. Am J Hematol 2010;85:868-871.
38. Hsi ED, Hoeltge G, Tubbs RR. Biclonal chronic lymphocytic leukemia. Am J Clin Pathol 2000;113:798-804.
39. Chang H, Cerny J. Molecular characterization of chronic lymphocytic leukemia with two distinct cell populations: Evidence for separate clonal origins. Am J Clin Pathol 2006;126:23-28.
40. Gonzalez-Campos J, Rios-Herranz E, De Blas-Orlando JM, et al. Chronic lymphocytic leukemia with two cellular populations: A biphenotypic or biclonal disease. Ann Hematol 1997;74:243-246.
41. Cao F, Amato D, Wang C. Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B-cell clones. Am J Hematol 2011;86:782.